Dr. Andreas Stange of TÜV SÜD talks about the practical impact of the new IVD regulation, how it will affect manufacturers and notified bodies, challenges in validation, and practical advice to prepare for these changes in companion diagnostics. For more information, please visit http://www.MolecularDXEurope.com/MDXE_Content.aspx?id=190671